Growth Disorders Codexery

Silver–Russell syndrome

A rare congenital growth disorder named after two physicians.

Silver–Russell syndrome

Silver–Russell syndrome (SRS), sometimes called Silver–Russell dwarfism, is a rare congenital growth disorder. In the United States, it is more commonly referred to as Russell–Silver syndrome, while elsewhere it is called Silver–Russell syndrome. It belongs to a group of 200 types of dwarfism and is one of five types of primordial dwarfism. The condition affects about one in every 50,000 to 100,000 births, and it occurs equally in males and females.

**Signs and symptoms** There is no definitive test to confirm SRS in every case, though many individuals have a specific genetic marker. Instead, a diagnosis is usually made in children who show several of the following symptoms. The most noticeable early sign is intrauterine growth restriction (IUGR), combined with other features. These include being small for gestational age at birth (often weighing less than 2.8 kg, or two or more standard deviations below the average weight of 2.8 kg). Infants may have feeding problems, showing little interest in eating and taking only small amounts with difficulty. Hypoglycemia is common, as is excessive sweating, especially at night, along with pale or grayish skin—this can signal low blood sugar. The face is often triangular, with a small jaw and pointed chin that tends to become less pronounced with age, and the mouth may curve downward. Younger children may have a blue tint to the whites of their eyes. Head circumference is often normal, making it look large compared to the small body. The fontanelle (soft spot) may be wide and close later than usual. Clinodactyly (curved fingers) is common. Body asymmetry occurs, with one side growing more slowly than the other. Growth remains poor, with no "catch-up" to normal growth curves, resulting in a low BMI. Other possible symptoms include precocious puberty, low muscle tone, gastroesophageal reflux disease, a notable lack of subcutaneous fat, constipation (sometimes severe), and, rarely, heart defects such as ventricular or atrial septal defects. The earliest signs are growth-related, typically noticed at birth and persisting throughout life. Children with SRS may initially grow at a normal rate for their age but rarely catch up to average size later in childhood. Without growth hormone treatment, average adult height is about 4 feet 11 inches (149.9 cm) for males and 4 feet 7 inches (139.7 cm) for females.

Field
Medicine, Genetics
Known for
First documenting the congenital growth disorder now called Silver–Russell syndrome
Birth
Not specified in source
Death
Not specified in source
Nationality
Not specified in source

Lore & Background

Henry Silver first documented the syndrome in 1953 when describing two children who had many of the symptoms, specifically the asymmetry part of the symptoms. Alexander Russell documented his findings in 1954, related to five children with Silver–Russell syndrome, two of whom had asymmetry, completely independent from Henry Silver. Initially, the syndrome was split into two different syndromes: Silver Syndrome for the syndrome with asymmetry, and Russell Syndrome for the syndrome without asymmetry. These were later combined to what is now known as Silver–Russell Syndrome.

Reader's Guide

Silver–Russell syndrome is significant as a rare congenital growth disorder that affects approximately one in 50,000 to 100,000 births. Its exact cause is unknown, but research points toward genetic and epigenetic components, including hypomethylation of H19 and IGF2 in about 50% of patients, and maternal uniparental disomy on chromosome 7 in 10% of cases. The syndrome requires lifelong interdisciplinary care, with growth hormone therapy often prescribed to improve growth and final adult height. Diagnosis has historically been clinical, but an international consensus in 2017 detailed molecular testing steps, including testing for 11p15 loss of methylation and mUPD7. The condition is also associated with assisted reproductive technologies such as in vitro fertilization. The average adult height without growth hormone treatment is 4'11" for males and 4'7" for females.

Did You Know?

More in Growth disorders 1-24

Spotted an error? Know more?

Reader corrections go straight into our review queue. Suggest an edit · How this site is sourced

Comments

Loading…
Open in the interactive codex →